Minimally invasive skull base surgery is a cutting-edge technique used to treat tumors and abnormalities located at the base of the skull, including pituitary tumors, meningiomas, schwannomas, and chordomas. This complex area is surrounded by critical structures such as the brainstem, cranial nerves, and major blood vessels. Minimally invasive approaches allow surgeons to access these deep-seated lesions with reduced risk and greater accuracy, often avoiding large incisions or bone removal.
The procedure typically involves endonasal (through the nose) or keyhole craniotomy techniques, utilizing advanced imaging, neuronavigation, and high-definition endoscopes. These tools provide a clear and magnified view of the surgical area, enabling precise tumor removal while preserving vital neurological functions. By avoiding traditional open skull procedures, patients benefit from less pain, lower complication rates, and quicker recovery.
This approach is ideal for patients with both benign and malignant skull base conditions, offering an effective solution with minimal disruption to brain tissue. Minimally invasive skull base surgery represents a significant advancement in neurosurgical care—combining safety, efficacy, and innovation to improve patient outcomes and quality of life.
